Credentials
Positions
- Clinical Assistant Professor, Department of Medicine at NYU Grossman School of Medicine
Education and Training
- Fellowship, Maimonides Medical Center, Hematology Oncology, 2022
- Residency, Montefiore Medical Center, 2019
- MD from Yale University, 2016
Is this your profile?
Edit profileInsurance Plans Accepted
Please call the office for information about accepted insurance plans.
Jason E. Sandler, MD does not accept insurance.
Clinical Trials and Research Studies
-
A PHASE III RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED STUDY EVALUATING ATEZOLIZUMAB AND BEVACIZUMAB WITH AND WITHOUT TIRAGOLUMAB IN PATIENTS WITH UNTREATED LOCALLY ADVANCED OR METASTATIC HEPATOCELLULAR CARCINOMA
-
EMBER-4: A Randomized Open-Label Phase 3 Study of Adjuvant Imlunestrant vs Standard Adjuvant Endocrine Therapy in Patients who have Previously Received 2 to 5 years of Adjuvant Endocrine Therapy for ER+ HER2- Early Breast Cancer with an Increased Risk of Recurrence.
Publications
-
Sukrithan, Vineeth; Sandler, Jason; Gucalp, Rasim; Gralla, Richard; Halmos, Balázs
Clinical lung cancer. 2019 05 ; 20(3):e242-e246
-
Sandler, Jason E; D'Aiello, Angelica; Halmos, Balazs
Journal of thoracic disease. 2019 May ; 11(5):2117-2125
-
Sandler, Jason E; Huang, Huang; Zhao, Nan; Wu, Weiwei; Liu, Fangfang; Ma, Shuangge; Udelsman, Robert; Zhang, Yawei
Cancer epidemiology biomarkers & prevention. 2018 03 ; 27(3):285-294